ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Scopolamine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: June 2025
|
Report Code: QYRE-Auto-4Y2681
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Scopolamine Market Insights Forecast to 2026
BUY CHAPTERS

Global Scopolamine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-4Y2681
Report
June 2025
Pages:127
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Alkaloids of Australia
Boehringer Ingelheim
Fine Chemicals Corporation
Phytex Australia
Alchem International
Guangzhou Hanfang
Alkaloids Corporation
Luyin

Scopolamine Market Size

In 2024, the global market size of Scopolamine was estimated to be worth US$ 11.9 million and is forecast to reach approximately US$ 15.9 million by 2031 with a CAGR of 4.2% during the forecast period 2025-2031.

Scopolamine Market

Scopolamine Market

Scopolamine is a medication used in the treatment of motion sickness and postoperative nausea and vomiting. Scopolamine is used to prevent nausea and vomiting caused by motion sickness or from anesthesia given during surgery.
The major players in global Scopolamine market include Alkaloids of Australia, Boehringer Ingelheim, Fine Chemicals Corporation, etc. The top 3 players occupy about 55% shares of the global market. Australia and Europe are main markets, they occupy about 60% of the global market. Scopolamine Hydrobromide is the main type, with a share about 45%. Patches is the main application, which holds a share about 60%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Scopolamine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Scopolamine.
The Scopolamine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Scopolamine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Scopolamine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Scopolamine Market Report

Report Metric Details
Report Name Scopolamine Market
Forecasted market size in 2031 approximately US$ 15.9 million
CAGR 4.2%
Forecasted years 2025 - 2031
Segment by Type
  • Scopolamine Butylbromide
  • Scopolamine Hydrobromide
  • Others
Segment by Application
  • Tablets
  • Injection
  • Patches
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Alkaloids of Australia, Boehringer Ingelheim, Fine Chemicals Corporation, Phytex Australia, Alchem International, Guangzhou Hanfang, Alkaloids Corporation, Luyin
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Scopolamine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of Scopolamine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Scopolamine sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the Scopolamine Market size in 2031?

Ans: The Scopolamine Market size in 2031 will be approximately US$ 15.9 million.

What is the market share of major companies in Scopolamine Market?

Ans: The top 3 players occupy about 55% shares of the global market.

What is the Scopolamine Market share by type?

Ans: Scopolamine Hydrobromide is the main type, with a share about 45%.

What is the Scopolamine Market share by application?

Ans: Patches is the main application, which holds a share about 60%.

Who are the main players in the Scopolamine Market report?

Ans: The main players in the Scopolamine Market are Alkaloids of Australia, Boehringer Ingelheim, Fine Chemicals Corporation, Phytex Australia, Alchem International, Guangzhou Hanfang, Alkaloids Corporation, Luyin

What are the Application segmentation covered in the Scopolamine Market report?

Ans: The Applications covered in the Scopolamine Market report are Tablets, Injection, Patches

What are the Type segmentation covered in the Scopolamine Market report?

Ans: The Types covered in the Scopolamine Market report are Scopolamine Butylbromide, Scopolamine Hydrobromide, Others

1 Study Coverage
1.1 Scopolamine Product Introduction
1.2 Market by Type
1.2.1 Global Scopolamine Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Scopolamine Butylbromide
1.2.3 Scopolamine Hydrobromide
1.2.4 Others
1.3 Market by Application
1.3.1 Global Scopolamine Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Tablets
1.3.3 Injection
1.3.4 Patches
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Scopolamine Market Size Estimates and Forecasts
2.1.1 Global Scopolamine Revenue 2020-2031
2.1.2 Global Scopolamine Sales 2020-2031
2.2 Scopolamine Market Size by Region: 2024 Versus 2031
2.3 Scopolamine Sales by Region (2020-2031)
2.3.1 Global Scopolamine Sales by Region: 2020-2025
2.3.2 Global Scopolamine Sales Forecast by Region (2026-2031)
2.3.3 Global Scopolamine Sales Market Share by Region (2020-2031)
2.4 Scopolamine Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Scopolamine Revenue by Region: 2020-2025
2.4.2 Global Scopolamine Revenue Forecast by Region (2026-2031)
2.4.3 Global Scopolamine Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Scopolamine Sales by Type (2020-2031)
3.1.1.1 Global Scopolamine Sales Volume by Type (2020-2031)
3.1.1.2 Global Scopolamine Sales Market Share by Type (2020-2031)
3.1.2 Global Scopolamine Revenue by Type (2020-2031)
3.1.2.1 Global Scopolamine Revenue by Type (2020-2031)
3.1.2.2 Global Scopolamine Revenue Market Share by Type (2020-2031)
3.1.3 Scopolamine Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Scopolamine Sales by Application (2020-2031)
3.2.1.1 Global Scopolamine Sales Volume by Application (2020-2031)
3.2.1.2 Global Scopolamine Sales Market Share by Application (2020-2031)
3.2.2 Global Scopolamine Revenue by Application (2020-2031)
3.2.2.1 Global Scopolamine Revenue by Application (2020-2031)
3.2.2.2 Global Scopolamine Revenue Market Share by Application (2020-2031)
3.2.3 Scopolamine Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Scopolamine Butylbromide of Scopolamine Revenue Market Share by Application
3.3.2 Scopolamine Hydrobromide of Scopolamine Revenue Market Share by Application
3.3.3 Others of Scopolamine Revenue Market Share by Application
4 Global Scopolamine by Manufacturers
4.1 Global Top Scopolamine Manufacturers by Sales (2020-2025)
4.1.1 Global Scopolamine Sales by Manufacturer (2020-2025)
4.1.2 Global Scopolamine Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Scopolamine Manufacturers by Revenue (2020-2025)
4.2.1 Global Scopolamine Revenue by Manufacturer (2020-2025)
4.2.2 Global Scopolamine Revenue Share by Manufacturer (2020-2025)
4.3 Global Scopolamine Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Scopolamine Manufacturers Covered: Ranking by Revenue
4.4.2 Global Scopolamine Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Scopolamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Scopolamine Manufacturing Base Distribution, Product Type
4.5.1 Scopolamine Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Scopolamine Market
4.5.3 Manufacturers Scopolamine Product Type and Application
4.5.4 Scopolamine Butylbromide Market Sales of Scopolamine by Manufacturer
4.5.5 Scopolamine Hydrobromide Market Sales of Scopolamine by Manufacturer
4.5.6 Others Market Sales of Scopolamine by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Alkaloids of Australia
5.1.1 Alkaloids of Australia Company Information
5.1.2 Alkaloids of Australia Description, Business Overview
5.1.3 Alkaloids of Australia Scopolamine Products Offered
5.1.4 Alkaloids of Australia Scopolamine Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Alkaloids of Australia Scopolamine Sales by Product in 2024
5.1.6 Alkaloids of Australia Scopolamine Sales by Application in 2024
5.1.7 Alkaloids of Australia Scopolamine Sales by Geographic Area in 2024
5.1.8 Alkaloids of Australia Recent Developments
5.2 Boehringer Ingelheim
5.2.1 Boehringer Ingelheim Company Information
5.2.2 Boehringer Ingelheim Description, Business Overview
5.2.3 Boehringer Ingelheim Scopolamine Products Offered
5.2.4 Boehringer Ingelheim Scopolamine Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Boehringer Ingelheim Scopolamine Sales by Product in 2024
5.2.6 Boehringer Ingelheim Scopolamine Sales by Application in 2024
5.2.7 Boehringer Ingelheim Scopolamine Sales by Geographic Area in 2024
5.2.8 Boehringer Ingelheim Recent Developments
5.3 Fine Chemicals Corporation
5.3.1 Fine Chemicals Corporation Company Information
5.3.2 Fine Chemicals Corporation Description, Business Overview
5.3.3 Fine Chemicals Corporation Scopolamine Products Offered
5.3.4 Fine Chemicals Corporation Scopolamine Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Fine Chemicals Corporation Scopolamine Sales by Product in 2024
5.3.6 Fine Chemicals Corporation Scopolamine Sales by Application in 2024
5.3.7 Fine Chemicals Corporation Scopolamine Sales by Geographic Area in 2024
5.3.8 Fine Chemicals Corporation Recent Developments
5.4 Phytex Australia
5.4.1 Phytex Australia Company Information
5.4.2 Phytex Australia Description, Business Overview
5.4.3 Phytex Australia Scopolamine Products Offered
5.4.4 Phytex Australia Scopolamine Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Phytex Australia Scopolamine Sales by Product in 2024
5.4.6 Phytex Australia Scopolamine Sales by Application in 2024
5.4.7 Phytex Australia Scopolamine Sales by Geographic Area in 2024
5.4.8 Phytex Australia Recent Developments
5.5 Alchem International
5.5.1 Alchem International Company Information
5.5.2 Alchem International Description, Business Overview
5.5.3 Alchem International Scopolamine Products Offered
5.5.4 Alchem International Scopolamine Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Alchem International Scopolamine Sales by Product in 2024
5.5.6 Alchem International Scopolamine Sales by Application in 2024
5.5.7 Alchem International Scopolamine Sales by Geographic Area in 2024
5.5.8 Alchem International Recent Developments
5.6 Guangzhou Hanfang
5.6.1 Guangzhou Hanfang Company Information
5.6.2 Guangzhou Hanfang Description, Business Overview
5.6.3 Guangzhou Hanfang Scopolamine Products Offered
5.6.4 Guangzhou Hanfang Scopolamine Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Guangzhou Hanfang Scopolamine Sales by Product in 2024
5.6.6 Guangzhou Hanfang Scopolamine Sales by Application in 2024
5.6.7 Guangzhou Hanfang Scopolamine Sales by Geographic Area in 2024
5.6.8 Guangzhou Hanfang Recent Developments
5.7 Alkaloids Corporation
5.7.1 Alkaloids Corporation Company Information
5.7.2 Alkaloids Corporation Description, Business Overview
5.7.3 Alkaloids Corporation Scopolamine Products Offered
5.7.4 Alkaloids Corporation Scopolamine Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Alkaloids Corporation Scopolamine Sales by Product in 2024
5.7.6 Alkaloids Corporation Scopolamine Sales by Application in 2024
5.7.7 Alkaloids Corporation Scopolamine Sales by Geographic Area in 2024
5.7.8 Alkaloids Corporation Recent Developments
5.8 Luyin
5.8.1 Luyin Company Information
5.8.2 Luyin Description, Business Overview
5.8.3 Luyin Scopolamine Products Offered
5.8.4 Luyin Scopolamine Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Luyin Scopolamine Sales by Product in 2024
5.8.6 Luyin Scopolamine Sales by Application in 2024
5.8.7 Luyin Scopolamine Sales by Geographic Area in 2024
5.8.8 Luyin Recent Developments
6 North America
6.1 North America Scopolamine Market Size YoY Growth 2020-2031
6.2 North America Scopolamine Market Facts & Figures by Country
6.2.1 North America Scopolamine Sales by Country (2020-2031)
6.2.2 North America Scopolamine Revenue by Country (2020-2031)
6.3 North America Scopolamine Sales by Type (2020-2025)
6.4 North America Scopolamine Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Scopolamine Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Scopolamine Market Facts & Figures by Region
7.2.1 Asia-Pacific Scopolamine Sales by Region (2020-2031)
7.2.2 Asia-Pacific Scopolamine Revenue by Region (2020-2031)
7.3 Asia-Pacific Scopolamine Sales by Type (2020-2025)
7.4 Asia-Pacific Scopolamine Sales by Application (2020-2025)
8 Europe
8.1 Europe Scopolamine Market Size YoY Growth 2020-2031
8.2 Europe Scopolamine Market Facts & Figures by Country
8.2.1 Europe Scopolamine Sales by Country (2020-2031)
8.2.2 Europe Scopolamine Revenue by Country (2020-2031)
8.3 Europe Scopolamine Sales by Type (2020-2025)
8.4 Europe Scopolamine Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Scopolamine Market Size YoY Growth 2020-2031
9.2 Latin America Scopolamine Market Facts & Figures by Country
9.2.1 Latin America Scopolamine Sales by Country (2020-2031)
9.2.2 Latin America Scopolamine Revenue by Country (2020-2031)
9.3 Latin America Scopolamine Sales by Type (2020-2025)
9.4 Latin America Scopolamine Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Scopolamine Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Scopolamine Market Facts & Figures by Country
10.2.1 Middle East and Africa Scopolamine Sales by Country (2020-2031)
10.2.2 Middle East and Africa Scopolamine Revenue by Country (2020-2031)
10.3 Middle East and Africa Scopolamine Sales by Type (2020-2025)
10.4 Middle East and Africa Scopolamine Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Scopolamine Supply Chain Analysis
11.2 Scopolamine Key Raw Materials and Upstream Suppliers
11.3 Scopolamine Clients Analysis
11.4 Scopolamine Sales Channel and Sales Model Analysis
11.4.1 Scopolamine Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Scopolamine Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Scopolamine Distributors
12 Scopolamine Market Dynamics
12.1 Scopolamine Industry Trends
12.2 Scopolamine Market Drivers
12.3 Scopolamine Market Challenges
12.4 Scopolamine Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Alkaloids of Australia
Boehringer Ingelheim
Fine Chemicals Corporation
Phytex Australia
Alchem International
Guangzhou Hanfang
Alkaloids Corporation
Luyin
List of Tables
 Table 1. Global Scopolamine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Scopolamine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Scopolamine Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Scopolamine Sales by Region (2020-2025) & (K Units)
 Table 5. Global Scopolamine Sales Forecast by Region (2026-2031) & (K Units)
 Table 6. Global Scopolamine Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global Scopolamine Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 8. Global Scopolamine Sales Volume by Type (2020-2025) & (K Units)
 Table 9. Global Scopolamine Sales Volume by Type (2026-2031) & (K Units)
 Table 10. Global Scopolamine Revenue by Type (2020-2025) & (US$ Million)
 Table 11. Global Scopolamine Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 12. Global Scopolamine Sales Volume by Application (2020-2025) & (K Units)
 Table 13. Global Scopolamine Sales Volume by Application (2026-2031) & (K Units)
 Table 14. Global Scopolamine Revenue by Application (2020-2025) & (US$ Million)
 Table 15. Global Scopolamine Revenue by Application (2026-2031) & (US$ Million)
 Table 16. Global Scopolamine Sales by Manufacturer (2020-2025) & (K Units)
 Table 17. Global Scopolamine Sales Share by Manufacturer (2020-2025)
 Table 18. Scopolamine Revenue by Manufacturer (2020-2025) & (US$ Million)
 Table 19. Scopolamine Revenue Share by Manufacturer (2020-2025)
 Table 20. Key Manufacturers Scopolamine Price (2020-2025) & (USD/Unit)
 Table 21. Ranking of Global Top Scopolamine Manufacturers by Revenue (US$ Million) in 2024
 Table 22. Global Scopolamine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 23. Global Scopolamine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Scopolamine as of 2024)
 Table 24. Scopolamine Manufacturers Manufacturing Base Distribution and Headquarters
 Table 25. Date of International Manufacturers Enter into Scopolamine Market
 Table 26. Manufacturers Scopolamine Product Type and Application
 Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 28. Alkaloids of Australia Company Information
 Table 29. Alkaloids of Australia Description and Business Overview
 Table 30. Alkaloids of Australia Scopolamine Product
 Table 31. Alkaloids of Australia Scopolamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 32. Alkaloids of Australia Sales Proportion of Scopolamine by Product in 2024
 Table 33. Alkaloids of Australia Sales Proportion of Scopolamine by Application in 2024
 Table 34. Alkaloids of Australia Sales Proportion of Scopolamine by Geographic Area in 2024
 Table 35. Alkaloids of Australia Recent Developments
 Table 36. Boehringer Ingelheim Company Information
 Table 37. Boehringer Ingelheim Description and Business Overview
 Table 38. Boehringer Ingelheim Scopolamine Product
 Table 39. Boehringer Ingelheim Scopolamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 40. Boehringer Ingelheim Sales Proportion of Scopolamine by Product in 2024
 Table 41. Boehringer Ingelheim Sales Proportion of Scopolamine by Application in 2024
 Table 42. Boehringer Ingelheim Sales Proportion of Scopolamine by Geographic Area in 2024
 Table 43. Boehringer Ingelheim Recent Developments
 Table 44. Fine Chemicals Corporation Company Information
 Table 45. Fine Chemicals Corporation Description and Business Overview
 Table 46. Fine Chemicals Corporation Scopolamine Product
 Table 47. Fine Chemicals Corporation Scopolamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 48. Fine Chemicals Corporation Sales Proportion of Scopolamine by Product in 2024
 Table 49. Fine Chemicals Corporation Sales Proportion of Scopolamine by Application in 2024
 Table 50. Fine Chemicals Corporation Sales Proportion of Scopolamine by Geographic Area in 2024
 Table 51. Fine Chemicals Corporation Recent Developments
 Table 52. Phytex Australia Company Information
 Table 53. Phytex Australia Description and Business Overview
 Table 54. Phytex Australia Scopolamine Product
 Table 55. Phytex Australia Scopolamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 56. Phytex Australia Sales Proportion of Scopolamine by Product in 2024
 Table 57. Phytex Australia Sales Proportion of Scopolamine by Application in 2024
 Table 58. Phytex Australia Sales Proportion of Scopolamine by Geographic Area in 2024
 Table 59. Phytex Australia Recent Developments
 Table 60. Alchem International Company Information
 Table 61. Alchem International Description and Business Overview
 Table 62. Alchem International Scopolamine Product
 Table 63. Alchem International Scopolamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 64. Alchem International Sales Proportion of Scopolamine by Product in 2024
 Table 65. Alchem International Sales Proportion of Scopolamine by Application in 2024
 Table 66. Alchem International Sales Proportion of Scopolamine by Geographic Area in 2024
 Table 67. Alchem International Recent Developments
 Table 68. Guangzhou Hanfang Company Information
 Table 69. Guangzhou Hanfang Description and Business Overview
 Table 70. Guangzhou Hanfang Scopolamine Product
 Table 71. Guangzhou Hanfang Scopolamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 72. Guangzhou Hanfang Sales Proportion of Scopolamine by Product in 2024
 Table 73. Guangzhou Hanfang Sales Proportion of Scopolamine by Application in 2024
 Table 74. Guangzhou Hanfang Sales Proportion of Scopolamine by Geographic Area in 2024
 Table 75. Guangzhou Hanfang Recent Developments
 Table 76. Alkaloids Corporation Company Information
 Table 77. Alkaloids Corporation Description and Business Overview
 Table 78. Alkaloids Corporation Scopolamine Product
 Table 79. Alkaloids Corporation Scopolamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 80. Alkaloids Corporation Sales Proportion of Scopolamine by Product in 2024
 Table 81. Alkaloids Corporation Sales Proportion of Scopolamine by Application in 2024
 Table 82. Alkaloids Corporation Sales Proportion of Scopolamine by Geographic Area in 2024
 Table 83. Alkaloids Corporation Recent Developments
 Table 84. Luyin Company Information
 Table 85. Luyin Description and Business Overview
 Table 86. Luyin Scopolamine Product
 Table 87. Luyin Scopolamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Luyin Sales Proportion of Scopolamine by Product in 2024
 Table 89. Luyin Sales Proportion of Scopolamine by Application in 2024
 Table 90. Luyin Sales Proportion of Scopolamine by Geographic Area in 2024
 Table 91. Luyin Recent Developments
 Table 92. North America Scopolamine Sales by Country (2020-2025) & (K Units)
 Table 93. North America Scopolamine Sales by Country (2026-2031) & (K Units)
 Table 94. North America Scopolamine Revenue by Country (2020-2025) & (US$ Million)
 Table 95. North America Scopolamine Revenue by Country (2026-2031) & (US$ Million)
 Table 96. North America Scopolamine Sales by Type (2020-2025) & (K Units)
 Table 97. North America Scopolamine Sales by Application (2020-2025) & (K Units)
 Table 98. Asia-Pacific Scopolamine Sales by Region (2020-2025) & (K Units)
 Table 99. Asia-Pacific Scopolamine Sales by Region (2026-2031) & (K Units)
 Table 100. Asia-Pacific Scopolamine Revenue by Region (2020-2025) & (US$ Million)
 Table 101. Asia-Pacific Scopolamine Revenue by Region (2026-2031) & (US$ Million)
 Table 102. Asia-Pacific Scopolamine Sales by Type (2020-2025) & (K Units)
 Table 103. Asia-Pacific Scopolamine Sales by Application (2020-2025) & (K Units)
 Table 104. Europe Scopolamine Sales by Country (2020-2025) & (K Units)
 Table 105. Europe Scopolamine Sales by Country (2026-2031) & (K Units)
 Table 106. Europe Scopolamine Revenue by Country (2020-2025) & (US$ Million)
 Table 107. Europe Scopolamine Revenue by Country (2026-2031) & (US$ Million)
 Table 108. Europe Scopolamine Sales by Type (2020-2025) & (K Units)
 Table 109. Europe Scopolamine Sales by Application (2020-2025) & (K Units)
 Table 110. Latin America Scopolamine Sales by Country (2020-2025) & (K Units)
 Table 111. Latin America Scopolamine Sales by Country (2026-2031) & (K Units)
 Table 112. Latin America Scopolamine Revenue by Country (2020-2025) & (US$ Million)
 Table 113. Latin America Scopolamine Revenue by Country (2026-2031) & (US$ Million)
 Table 114. Latin America Scopolamine Sales by Type (2020-2025) & (K Units)
 Table 115. Latin America Scopolamine Sales by Application (2020-2025) & (K Units)
 Table 116. Middle East and Africa Scopolamine Sales by Country (2020-2025) & (K Units)
 Table 117. Middle East and Africa Scopolamine Sales by Country (2026-2031) & (K Units)
 Table 118. Middle East and Africa Scopolamine Revenue by Country (2020-2025) & (US$ Million)
 Table 119. Middle East and Africa Scopolamine Revenue by Country (2026-2031) & (US$ Million)
 Table 120. Middle East and Africa Scopolamine Sales by Type (2020-2025) & (K Units)
 Table 121. Middle East and Africa Scopolamine Sales by Application (2020-2025) & (K Units)
 Table 122. Scopolamine Key Raw Materials, Industry Status and Trend
 Table 123. Scopolamine Key Raw Materials and Upstream Suppliers
 Table 124. Scopolamine Clients Status and Trend
 Table 125. Scopolamine Typical Clients
 Table 126. Scopolamine Distributors
 Table 127. Scopolamine Market Trends
 Table 128. Scopolamine Market Drivers
 Table 129. Scopolamine Market Challenges
 Table 130. Scopolamine Market Restraints
 Table 131. Research Programs/Design for This Report
 Table 132. Key Data Information from Secondary Sources
 Table 133. Key Data Information from Primary Sources
 Table 134. QYR Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Scopolamine Product Picture
 Figure 2. Global Scopolamine Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Scopolamine Sales Market Share by Type in 2024 & 2031
 Figure 4. Scopolamine Butylbromide Product Picture
 Figure 5. Scopolamine Hydrobromide Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Scopolamine Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 8. Global Scopolamine Sales Market Share by Application in 2024 & 2031
 Figure 9. Tablets
 Figure 10. Injection
 Figure 11. Patches
 Figure 12. Scopolamine Report Years Considered
 Figure 13. Global Scopolamine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Scopolamine Market Size 2020-2031 (US$ Million)
 Figure 15. Global Scopolamine Sales 2020-2031 (K Units)
 Figure 16. Global Scopolamine Sales Market Share Forecast by Region (2020-2031)
 Figure 17. Global Scopolamine Revenue Market Share by Region (2020-2031)
 Figure 18. Global Scopolamine Sales Market Share Forecast by Type (2020-2031)
 Figure 19. Global Scopolamine Revenue Market Share Forecast by Type (2020-2031)
 Figure 20. Scopolamine Average Selling Price (ASP) by Type (2020-2025) & (USD/Unit)
 Figure 21. Global Scopolamine Sales Market Share Forecast by Application (2020-2031)
 Figure 22. Global Scopolamine Revenue Market Share Forecast by Application (2020-2031)
 Figure 23. Scopolamine Average Selling Price (ASP) by Application (2020-2025) & (USD/Unit)
 Figure 24. Scopolamine Butylbromide of Scopolamine Revenue Market Share by Application, 2024 VS 2031
 Figure 25. Scopolamine Hydrobromide of Scopolamine Revenue Market Share by Application, 2024 VS 2031
 Figure 26. Others of Scopolamine Revenue Market Share by Application, 2024 VS 2031
 Figure 27. Global Scopolamine Sales Share by Manufacturer in 2024
 Figure 28. Scopolamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 29. Scopolamine Butylbromide Market Sales Proportion by Manufacturer in 2024
 Figure 30. Scopolamine Hydrobromide Market Sales Proportion by Manufacturer in 2024
 Figure 31. Others Market Sales Proportion by Manufacturer in 2024
 Figure 32. North America Scopolamine Revenue 2020-2031 (US$ Million)
 Figure 33. North America Scopolamine Sales Market Share by Type (2020-2025)
 Figure 34. North America Scopolamine Sales Market Share by Application (2020-2025)
 Figure 35. Asia-Pacific Scopolamine Revenue 2020-2031 (US$ Million)
 Figure 36. Asia-Pacific Scopolamine Sales Market Share by Region (2020-2031)
 Figure 37. Asia-Pacific Scopolamine Revenue Market Share by Region (2020-2031)
 Figure 38. Asia-Pacific Scopolamine Sales Market Share by Type (2020-2025)
 Figure 39. Asia-Pacific Scopolamine Sales Market Share by Application (2020-2025)
 Figure 40. Europe Scopolamine Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 41. Europe Scopolamine Sales Market Share by Country (2020-2031)
 Figure 42. Europe Scopolamine Revenue Market Share by Country (2020-2031)
 Figure 43. Europe Scopolamine Sales Market Share by Type (2020-2025)
 Figure 44. Europe Scopolamine Sales Market Share by Application (2020-2025)
 Figure 45. Latin America Scopolamine Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 46. Latin America Scopolamine Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Scopolamine Revenue Market Share by Country (2020-2025)
 Figure 48. Latin America Scopolamine Sales Market Share by Type (2020-2025)
 Figure 49. Latin America Scopolamine Sales Market Share by Application (2020-2025)
 Figure 50. Middle East and Africa Scopolamine Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 51. Middle East and Africa Scopolamine Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Scopolamine Revenue Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Scopolamine Sales Market Share by Type (2020-2025)
 Figure 54. Middle East and Africa Scopolamine Sales Market Share by Application (2020-2025)
 Figure 55. Scopolamine Supply Chain (Upstream and Downstream Market)
 Figure 56. Global Production Market Share of Scopolamine Raw Materials by Region in 2024
 Figure 57. Scopolamine Distribution Channels
 Figure 58. Global Scopolamine Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 59. Global Scopolamine Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Hyoscine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Scopolamine Transdermal Patch Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Scopolamine Butylbromide Capsules Market Research Report 2024
Global Anticholinergic Travel Sickness Drugs Market Insights Forecast to 2030
Global Scopolamine Butylbromide for Injection Market Research Report 2024
Global Nausea And Vomiting Treatment Market Insights Forecast to 2030
Global Scopolamine Butylbromide Injection Market Research Report 2025
Cyclizine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ephedrine Market Insights Forecast to 2030
Global Atropine Market Insights Forecast to 2030
Anticholinergic Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Atropine Medication Market Research Report 2024
Antiemetic Patch Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Metoclopramide Market Research Report 2024
Global Esketamine Market Insights Forecast to 2030
Global Antihistamines Travel Sickness Drugs Market Insights Forecast to 2030
Global Antispasmodic and Anticholinergic H2 Blocking Agents Market Research Report 2024
Global Propacetamol Market Research Report 2024
Postoperative Nausea and Vomiting Management Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Medical Electronic Antiemetic Device Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions